Pitango

Pitango HealthTech Announces the First Closing of Its New Fund, Pitango HealthTech II

Retrieved on: 
Wednesday, September 6, 2023

HERZLIYA, Israel, Sept. 6, 2023 /PRNewswire/ -- Pitango HealthTech, Pitango VC's dedicated healthcare fund, today announced the first closing of its second dedicated healthcare fund, Pitango HealthTech II. Pitango HealthTech II, a $175M fund, will be dedicated to investing in entrepreneurs leveraging data science, AI, medical devices and novel biology at the forefront of the transformation of healthcare.

Key Points: 
  • HERZLIYA, Israel, Sept. 6, 2023 /PRNewswire/ -- Pitango HealthTech , Pitango VC's dedicated healthcare fund, today announced the first closing of its second dedicated healthcare fund, Pitango HealthTech II.
  • Pitango HealthTech II, a $175M fund, will be dedicated to investing in entrepreneurs leveraging data science, AI, medical devices and novel biology at the forefront of the transformation of healthcare.
  • Pitango HealthTech II invests in healthcare innovation, including the decentralization of healthcare, personalized medicine, medical devices and diagnostics, as well as artificial intelligence, software and data infrastructure.
  • Pitango HealthTech is part of the Pitango investment platform, operating alongside Pitango First and Pitango Growth Funds.

QuantHealth Announces $15M Series A for its AI Platform That Enhances Success of Clinical Trials

Retrieved on: 
Wednesday, August 30, 2023

Over 90 percent of drugs that make it to clinical trials fail to make it to market, amounting to a $50B waste each year.

Key Points: 
  • Over 90 percent of drugs that make it to clinical trials fail to make it to market, amounting to a $50B waste each year.
  • This happens because there are major gaps in the research needed to support clinical trials.
  • QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development.
  • The new funding will be used for commercial expansion, product development and expansion of the platform beyond clinical trials and into new use cases including regulatory support, and early R&D.

Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate Update

Retrieved on: 
Monday, June 5, 2023

(Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced changes to its executive leadership team and provided a corporate update.

Key Points: 
  • (Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced changes to its executive leadership team and provided a corporate update.
  • "I am excited to resume my corporate leadership responsibilities and look forward to continued engagement with our key stakeholders," said Dr. Mor.
  • "This transition of executive leadership to the company's founding team will focus on maintaining business continuity and ensuring clinical plan execution," continued Dr. Mor.
  • Adi's exceptional corporate leadership skills are complemented by her extensive knowledge in autoimmune, inflammatory and fibrotic diseases and broad experience in developing monoclonal antibodies.

Tech It Forward Hosts First Cartier Women's Initiative Impact Event in Israel

Retrieved on: 
Monday, March 27, 2023

TEL AVIV, Israel, March 27, 2023 /PRNewswire/ -- Tech It Forward , the Israeli innovation hub and partner of Cartier Women's Initiative (CWI), hosted the first CWI Impact event in Israel.

Key Points: 
  • TEL AVIV, Israel, March 27, 2023 /PRNewswire/ -- Tech It Forward , the Israeli innovation hub and partner of Cartier Women's Initiative (CWI), hosted the first CWI Impact event in Israel.
  • The event brought together women impact entrepreneurs, experienced professionals, and investors for a morning of networking, pitching, and collaboration.
  • The Cartier Women's Initiative team was led by Wingee Sampaio, the global program director, and Maeva Mendy, Community engagement manager.
  • Tech It Forward and CWI's collaboration in Israel aims to continue providing women impact entrepreneurs with the support, resources, and opportunities to succeed.

DriveNets Secures $262 Million in Series C Funding to Continue Disrupting the Telecommunications and Cloud Infrastructure Industry

Retrieved on: 
Wednesday, August 17, 2022

RA'ANANA, Israel, Aug. 17, 2022 /PRNewswire/ -- DriveNets, a leader in cloud-native networking solutions, today announced it has secured $262 million in a Series C venture capital funding round, considerably increasing the company's valuation over its January 2021 Series B round. The funding from this latest round of investment will be used to develop future technology solutions, pursue new business opportunities, and expand the company's global operations and support teams to support growing customer demand.

Key Points: 
  • The round was led by D2 Investments with the participation of DriveNets' current investors, including Bessemer Venture Partners, Pitango, D1 Capital, Atreides Management, and Harel Insurance Investments & Financial Services.
  • "DriveNets has demonstrated its ability to move the networking industry forward and has gained the trust of tier-1 operators," said Adam Fisher, Partner at Bessemer Venture Partners.
  • DriveNets also recently announced the addition of three cloud and networking industry veterans to its leadership team.
  • DriveNets' solution Network Cloud adapts the architectural model of cloud to telco-grade networking.

Quantum Source Goes Out of Stealth to Enable Useful Photonic Quantum Computers with Millions of Qubits

Retrieved on: 
Friday, July 1, 2022

Quantum Sources vision is to enable scaling quantum computers to millions of qubits with its breakthrough photonic technology.

Key Points: 
  • Quantum Sources vision is to enable scaling quantum computers to millions of qubits with its breakthrough photonic technology.
  • Oded Melamed, CEO and Co-Founder, Quantum Source: The difference between small quantum computers that are developed today, with tens or hundreds of qubits, and building efficient, large-scale quantum computers with millions of qubits is huge.
  • The photonic quantum technology that Quantum Source is developing will enable a dramatic leap forward and the realization of quantum computer systems with millions of qubits.
  • Quantum Source (QS) is located in Rehovot, Israel, and is developing breakthrough technology to enable a commercially viable photonic quantum computer with millions of qubits.

NTT Finance Invests in D-ID, World Leader in AI-Driven Creative Media

Retrieved on: 
Tuesday, May 31, 2022

TOKYO, May 31, 2022 /PRNewswire/ -- NTT Finance, financial group company of Japanese telecommunications giant NTT, invested in D-ID, the world leader in AI-driven creative media. The funding is part of D-ID's recent $25 million Series B round. The round was led by investment firm Macquarie Capital, with significant investments from Pitango, AXA Venture Partners, OurCrowd, OIF Ventures, Maverick and Marubeni. The new infusion brings D-ID's total funding to $48 million.

Key Points: 
  • TOKYO, May 31, 2022 /PRNewswire/ -- NTT Finance, financial group company of Japanese telecommunications giant NTT, invested in D-ID, the world leader in AI-driven creative media.
  • Investment in D-ID was facilitated by NTT Innovation Laboratory Israel (NTT Israel), a wholly owned subsidiary of NTT that serves as an internal strategic resource to breakthrough innovation from Israel.
  • NTT Israel's mission is to support the evolution of NTT Group customer businesses, promote innovation and digital transformation.
  • NTT FINANCE, which is the first company that NTT established in April 1985 after being privatized, offers financial settlements and finance services.

NTT Finance Invests in D-ID, World Leader in AI-Driven Creative Media

Retrieved on: 
Tuesday, May 31, 2022

TOKYO, May 31, 2022 /PRNewswire/ -- NTT Finance, financial group company of Japanese telecommunications giant NTT, invested in D-ID, the world leader in AI-driven creative media. The funding is part of D-ID's recent $25 million Series B round. The round was led by investment firm Macquarie Capital, with significant investments from Pitango, AXA Venture Partners, OurCrowd, OIF Ventures, Maverick and Marubeni. The new infusion brings D-ID's total funding to $48 million.

Key Points: 
  • TOKYO, May 31, 2022 /PRNewswire/ -- NTT Finance, financial group company of Japanese telecommunications giant NTT, invested in D-ID, the world leader in AI-driven creative media.
  • Investment in D-ID was facilitated by NTT Innovation Laboratory Israel (NTT Israel), a wholly owned subsidiary of NTT that serves as an internal strategic resource to breakthrough innovation from Israel.
  • NTT Israel's mission is to support the evolution of NTT Group customer businesses, promote innovation and digital transformation.
  • NTT FINANCE, which is the first company that NTT established in April 1985 after being privatized, offers financial settlements and finance services.

Takwin Announces Launch of New Fund Aimed at Elevating and Empowering High-Potential Arab Entrepreneurs in Israel to Bolster “Startup Nation”

Retrieved on: 
Tuesday, March 29, 2022

The Takwin 2 fund will aim to invest $80 million in early-stage capital for high-potential startups over a five-year term.

Key Points: 
  • The Takwin 2 fund will aim to invest $80 million in early-stage capital for high-potential startups over a five-year term.
  • We founded Takwin with the principal intention of leveling this playing field and bringing bright, ambitious Arab-Israelis into the fold.
  • Its not enough to invest money in Arab entrepreneurs in Israel, said Itzik Frid, Takwins managing partner and CEO.
  • The launch of the Takwin 2 fund comes on the heels of the success of its initial investment fund.

D-ID Closes $25 Million Funding Round, Bringing Total Funding For The Creative Reality™ Company to $48 million

Retrieved on: 
Tuesday, March 22, 2022

This new infusion brings D-ID's total funding to $48 million.

Key Points: 
  • This new infusion brings D-ID's total funding to $48 million.
  • D-ID uses AI and deep learning to develop reenactment-based products ranging from animating still photos to developing high-quality digital avatars.
  • In early March, the company was named by Fast Company as one of the Most Innovative Companies of 2022 in EMEA.
  • D-ID is a Tel Aviv-based Creative Reality startup specializing in patented video reenactment technology using AI and deep learning.